EMJ GOLD

Filter Advertise With Us

Person performing spinal tap or lumbar puncture

New Ionis drug gets FDA greelight for rare brain disorder

Zanvastro (zilganersen) becomes the first FDA-approved treatment for Alexander disease, a rare genetic brain disorder.

Person performing spinal tap or lumbar puncture

New Ionis drug gets FDA greelight for rare brain disorder

Zanvastro (zilganersen) becomes the first FDA-approved treatment for Alexander disease, a rare genetic brain disorder.

Pair of scissors cutting a piece of paper with JOBS written on it

ArsenalBio and TScan cut jobs to focus on in vivo

ArsenalBio and TScan reduce their workforces in order to focus on therapies that work by engineering patients’ cells inside the body.

Manchester skyline

MHRA launches health innovation sandbox in Manchester

Emerging healthcare technologies will be tested in real NHS settings under a new regulatory sandbox launched by the MHRA.

Novartis halts eight CAR-T cell therapy trials after deaths

Novartis has halted eight rap-cell trials after three patients died following severe immune reactions.

Man holding pills

FDA approves first-in-class drug for rare skin disease

The FDA has approved Roivant and Priovant’s Lisraya (brepocitinib) for dermatomyositis, offering patients the first targeted therapy.

AstraZeneca building

AstraZeneca asthma drug succeeds in oesophagus disease trial

AstraZeneca’s Tezspire (tezepelumab-ekko) has met its main goals in a late-stage trial for oesophagus disease.

FDA office building

J&J wins FDA nod for Imaavy in rare blood disorder

The US regulator has cleared Johnson & Johnson’s Imaavy (nipocalimab) for warm autoimmune haemolytic anaemia, or wAIHA.

Month in pharma news, explained

Month in pharma news, explained – August 2026

From the AZ-BMS merger rumour that rattled markets to a double UK approval for Eli Lilly’s weight loss pill, there’s plenty to discover.

Loading posts...

1 2 3 … 60 Next »